Lv5
1320 积分 2021-03-16 加入
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
23小时前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
4天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
4天前
已完结
Non-small-cell lung cancer
15天前
已完结
Non-small-cell lung cancer
15天前
已关闭
HLX22, an anti-HER-2 monoclonal antibody, in patients with advanced solid tumors overexpressing human epidermal growth factor receptor 2: an open-label, dose-escalation, phase 1 trial
2个月前
已完结
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
4个月前
已完结
Cancer incidence and mortality in China, 2022
4个月前
已完结
Immunotherapy in resectable NSCLC: Answering the question or questioning the answer?
5个月前
已完结
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
5个月前
已关闭
皖公网安备34019202002308
